ATAL 9

K152151 · Atlaim Corporation · MQB · Nov 10, 2015 · Radiology

Device Facts

• Record ID: K152151
• Device Name: ATAL 9
• Applicant: Atlaim Corporation
• Product Code: MQB · Radiology
• Decision Date: Nov 10, 2015
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 892.1680
• Device Class: Class 2

Intended Use

The ATAL 9 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures, excluding fluoroscopic, angiographic, and mammographic applications.

Device Story

ATAL 9 is a digital radiography system featuring a flat panel detector (FPD) designed to replace conventional film/screen systems. It captures X-ray signals and converts them into digital images for PACS integration. The device is a modification of the predicate (K113812), adding wireless connectivity (IEEE 802.11ac) and battery operation. It supports both wired (Gigabit Ethernet) and wireless interfaces. The system uses either CsI or GOS scintillators and supports automatic exposure detection (AED) or manual triggering. It is intended for use in clinical environments by healthcare professionals. The output is a DICOM-compliant digital image, which assists clinicians in diagnostic decision-making by providing filmless, high-resolution radiographic images. The device benefits patients by enabling efficient digital imaging workflows.

Clinical Evidence

Clinical images were acquired and evaluated by a board-certified radiologist. The study concluded that images from the ATAL 9 panel are as good as or better than those from the predicate panel. Clinical data was supplementary, as substantial equivalence was primarily supported by bench testing and the minor nature of the modifications.

Technological Characteristics

Digital X-ray receptor panel; 17x17 inch active area; 139 μm pixel pitch; CsI or GOS scintillator; 16-bit A/D conversion; Wired (Gigabit Ethernet) and Wireless (IEEE 802.11ac) connectivity; Rechargeable Lithium battery (10-hour life); Electrical safety per IEC 60601-1; EMC per IEC 60601-1-2; FCC compliant.

Indications for Use

Indicated for general radiographic imaging of human anatomy in patients requiring diagnostic X-ray procedures, excluding fluoroscopic, angiographic, and mammographic applications.

Regulatory Classification

Identification

A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Special Controls

*Classification.* Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Predicate Devices

• ATAL 8, ATAL 8c (K113812)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized graphic of three human profiles facing right, stacked on top of each other. The graphic is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

November 10, 2015

ATLAIM Corporation % Mr. Daniel Kamm Principal Engineer Kamm & Associates 8870 Ravello Court NAPLES FL 34114

Re: K152151

Trade/Device Name: ATAL 9 Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary x-ray system Regulatory Class: II Product Code: MQB Dated: October 14, 2015 Received: October 16, 2015

Dear Mr. Kamm:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D'Hara

For

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K152151

Device Name ATAL 9

Indications for Use (Describe)

The ATAL 9 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures, excluding fluoroscopic, and mammographic applications.

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------------------------------------------|-----------------------------------------------|
| <span style="font-size:100%;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) Summary 510(k) Number K152151 ATLAIM Corporation 5F, SMART BAY, 123, Beolmal-ro, Dongan-gu, Anyang-si, Gyeonggi-do, 431-804, Korea Tel [phone] FAX [phone] Date Prepared: November 3, 2015 Contact: Young Kim, President

- 1. Identification of the Device: Proprietary-Trade Name: ATAL 9 Classification Name: Stationary X-ray System Common/Usual Name: Digital X-Ray Receptor Panel Product Code: MOB Device Class/Regulation Number: Class II per regulation 892.1680
- 2. Equivalent legally marketed device: ATAL 8, ATAL 8c, K113812, Atlaim Corporation. Classification Name: Stationary X-ray System Common/Usual Name: Digital X-Ray Receptor Panel Product Code: MQB Device Class/Regulation Number: Class II per regulation 892.1680
- 3. Indications for Use (intended use) The ATAL 9 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures, excluding fluoroscopic, angiographic, and mammographic applications.
- 4. Description of the Device: The ATAL 9 is a MODIFICATION of our clearance K113812 wherein we have changed panel to a wireless version of the previously cleared panel/software combination. Going wireless with battery operation are the ONLY modifications. The available scintillators (CsI or GOS) remain the same. The triggering methods (AED or manual trigger) remain the same. When used with an electrical synchronization circuit the following generators are known to properly synchronize: Sedecal SHF Series and CPI 200 Series.

The ATAL 9 is a digital radiography system, featuring an integrated flat panel digital detector (FPD). ATAL 9 is designed to perform digital radiographic examinations as a replacement for conventional film. This integrated platform provides the benefits of PACS with the advantages of digital radiography for a filmless environment and improves cost effectiveness. The major functions and principle of operation of the modified panel are the same as our previous panel with a Wi-Fi wireless feature added.

- 5. Safety and Effectiveness, comparison to predicate device. The results of clinical image inspection, bench, and test laboratory results indicates that the new device is as safe and effective as the predicate device. Clinical images collected demonstrate equal or better image quality as compared to our predicate.

{4}------------------------------------------------

## 6. Substantial Equivalence Chart

| | ATAL 8 ATAL 8c, K113812 | ATAL 9 |
|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------|
| Intended<br>Use: | Indicated for use in general radiographic<br>images of human anatomy. It is intended to<br>replace radiographic film/screen systems in<br>all general-purpose diagnostic procedures,<br>excluding fluoroscopic, angiographic, and<br>mammographic applications. | UNCHANGED |
| Configuration | This submission is for the Digital Panel and<br>Software only, no generator or stand<br>provided. | UNCHANGED |
| | Digital Panel | |
| Pixel Pitch | 139 μm | SAME |
| Limiting<br>Resolution | Over 3 lp/mm | SAME |
| DQE (CSI) | At 2 lp/mm 27% | At 2 lp/mm 26% |
| MTF (CSI) | At 2 lp/mm 43% | At 2 lp/mm 42% |
| A/D<br>Conversion | 14 bits | 16 bits |
| Active Area | 17 x 17 inch | SAME |
| Dimensions/<br>Weights | 500(W)×500(L)×25(H)/ 7.8kg | 460(W)×461(L)×15(H)/ 2.9kg (2.4kg w/o<br>Battery) (up to 10 hours of battery life) |
| Pixels | 3,072 x 3072 (9.4 M. pixels) | SAME |
| Software | Outputs a DICOM image. | SAME as K113812 |
| DICOM | Yes | YES |
| Scintillator | Csl/GOS | UNCHANGED |
| Interface | Gigabit Ethernet | Wired : Gigabit Ethernet (1000BASE-T)<br>Wireless : IEEE802.11ac, backward compatible |
| Power source | AC Line | AC Line and/or Rechargeable Lithium Battery<br>(10 hr run time) |
| Photo | Image: ATAL 8 ATAL 8c, K113812 | Image: ATAL 9 |
| | ATAL 8 ATAL 8c, K113812 | ATAL 9 |
| Standards | Electrical Safety per IEC 60601-1 and EMC per<br>IEC 60601-1-2. | Electrical Safety per IEC 60601-1 and EMC per<br>IEC 60601-1-2 as well as IEEE 802.11ac.<br>Meets FCC requirements. |

{5}------------------------------------------------

- 7. Summary of Bench Testing Conducted: IEC Standards were employed for: Electrical Safety and Electromagnetic Compatibility. MTF and DQE measurements, Risk Analysis and Software verification were conducted in accordance with FDA guidance documents. As expected the DQE and MTF measurements show minimal differences, and the limiting resolution is the same. The software remains the same as in K113812. Wireless communication testing was performed to verify wireless connectivity. The device was also found to comply with FCC requirements for wireless operation. Bench testing was performed in accordance with the FDA Guidance for the Submission of 510(k)'s for Solid State X-ray Imaging Devices.
- 8. Summary of Clinical Testing: Clinical images were acquired and evaluated by a board certified radiologist who concluded the images from the new panel are as good as or better than the images acquired with the predicate panel, as required by the FDA Guidance for the Submission of 510(k)'s for Solid State X-ray Imaging Devices. The core technology of the panel remains the same. The provided clinical data was not used to support a determination of substantial equivalence due to the minor modifications and adequate bench testing data.
- 9. Conclusion: After analyzing bench, clinical image, and external laboratory testing to applicable standards, it is the conclusion of Atlaim that the ATAL 9 (Wireless) is as safe and effective as the predicate device. The Atlaim ATAL 9 has the same intended use as the legally marketed predicate device. Although the ATAL 9 has different technological characteristics, including the addition of wireless technology to the digital image receptor, those differences do not raise different questions of safety and effectiveness from the predicate device. The effects of these differences were adequately documented with bench testing data which showed that the ATAL 9 is substantially equivalent to the predicate device.